
OPC 2025: Early and Metastatic GI Cancers See Practice Changing Trial Results
Advances in gastrointestinal (GI) oncology are rapidly reshaping therapeutic strategies, particularly as immunotherapy and targeted treatments move into earlier lines of care. At the 2025 Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, …